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Filippo Rossi,c Mauro Morlacchinid and Marcello Durantia
The supplementation of foods with biologically active compounds can be a powerful approach for
improving diet and well being. In this study we separately included in pasta matrices a concentrate of
g-conglutin, a glucose-lowering protein from Lupinus albus seeds, an isolate of the other main lupin
storage proteins and ovalbumin, at a ratio corresponding to 125 mg of pure protein in 100 g of pasta.
With these products we fed rats made hyperglycaemic, for 3 weeks. Among the most relevant changes
measured in body and blood parameters were: (i) a signiﬁcant reduction in food intake of rats fed
g-conglutin concentrate supplemented pasta and a signiﬁcant limitation in the body weight increase in
rats fed a, b and d-conglutin isolate supplemented pasta, while the food conversion indices were
unchanged; (ii) a reduction in glycaemia upon glucose overload trial, especially in the g-conglutin
concentrate supplemented pasta fed animals, at a dose of 45 mg per kg body weight. The correlations
among the measured parameters are discussed. Overall, the results evidence the potentiality of
supplementing traditional foods with exogenous nutraceutical seed proteins to control body weight gain
and glycaemia.1. Introduction
The role of foods and food components on the prevention and
control of several diseases is increasingly being acknowledged
worldwide. Therefore, the need for improving the nutritional/
nutraceutical performance of foods to control expanding
syndromes, such as diabetes, obesity, metabolic syndrome,
overweight conditions and others, is crucial. One of the possible
ways is the supplementation of traditional foods with biologi-
cally active compounds. However, eﬀective examples in this
area are not frequent and oen technological/functional prob-
lems related to stability, eﬃciency, dosage of the compounds
and their sensorial eﬀects on foods prevent the implementation
of potentially relevant formulas.
Nowadays, a critical health issue is the control of diabetes
and obesity, which is already a public health emergency due toutritional Sciences (DeFENS), Universita`
, 20133 Milan, Italy. E-mail: jessica.
Tel: +39 02 503 16823
ne in Agricoltura – Unita` di Ricerca per la
le Varieta` Vegetali (CRA-SCV), Via Mulino
N), Universita` Cattolica del Sacro Cuore,
aly
ment (CERZOO), Localita` Possessione di
hemistry 2014their increasing incidence and prevalence throughout the
world.1 In this respect, the kinetics of glucose release and
absorption aer food ingestion and the resulting eﬀects on the
synthesis of and sensitivity to insulin, as well as the regulation
of satiety, are gaining interest for the prevention of diabetes and
obesity.
Lupin seeds and ours are among the natural foods which
have been claimed to have anti-diabetic properties by tradi-
tional medicine. As a matter of fact, the active principle
responsible for the glucose-lowering activity has unequivocally
been identied as the protein g-conglutin that, in Lupinus albus
seeds constitutes about 5% of total seed proteins, correspond-
ing to about 2 g of g-conglutin in 100 g of dry seeds or our.
Signicant variations in the g-conglutin content amongst L.
albus varieties have not been reported so far. Not only has this
lupin protein repeatedly been shown to decrease glycaemia in
animals and humans,2,3 but its interaction with the putative
target cells, including myocytes and hepatocytes,4,5 proved to
produce a number of eﬀects which have collectively been clas-
sied as insulin-mimetic activities. Despite this potentiality, no
study on the eﬀects of g-conglutin incorporated into a food
matrix has been undertaken so far.
Pasta is a traditional food which, for many structural and
technological reasons, can be considered an eﬀective vehicle for
bioactive proteins and peptides. Consequently, we have
prepared pasta samples supplemented with a g-conglutinFood Funct., 2014, 5, 375–380 | 375
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View Article Onlineconcentrate or the isolate of remnant main lupin seed proteins
as well as with ovalbumin, as a control. With these samples, we
have fed rats for three weeks and measured various body and
blood parameters.
Thus, the objective of this work was to compare the eﬀects of
a diet based on pasta containing small amounts of specic
lupin protein fractions on some physiological and biochemical
parameters.
2. Material and methods
2.1 Materials
White lupin seeds (Lupinus albus, var. Multitalia) were a kind
gi from Agroservice S.p.A., Rocchetta, San Severino Marche,
Italy.
Ovalbumin was purchased from Sigma Aldrich (Milan, Italy).
Chemicals were all reagent grade by Sigma Aldrich (Milan,
Italy), unless specied otherwise.
2.2 Lupin protein fractionation
Mature dry seeds of Lupinus albus, L. were used as a source of
the protein fractions. Lupin proteins were fractionated as
described by Sironi with someminor modications.6 Briey, the
seeds were milled to our which was sieved through an 80 mesh
sieve. The proteins in the our were extracted with distilled
water containing 0.5 M NaCl in the ratio 1/10 w/v at 4 C for
3 hours. The pH was constantly kept between 7.0 and 9.0 by the
addition of 0.1 M NaOH. The slurry was centrifuged at 10 000 
g at 4 C for 30 min. The supernatant was adjusted to pH 4.5–5.5
with acetic acid for protein isoelectric precipitation. The
resulting suspension was centrifuged as above. The pellet was
washed twice with distilled water at pH around 5.0. The washed
pellet was then freeze dried. This fraction consisted of the iso-
electrically precipitated main lupin proteins. The fraction
soluble at pH 5.0 was adjusted to pH 7.0 with 0.1 M NaOH and
20 mM ZnCl2 was added. The resulting suspension was centri-
fuged as above and the pellet recovered. The pellet was washed
twice with distilled water and freeze dried. As it will be seen
below, this fraction mainly consisted of g-conglutin.
2.3 SDS-PAGE of the protein fractions
The protein samples were suspended in the sample buﬀer in the
ratio 1 : 20 (w/v). The sample buﬀer consisted of 0.25 M Tris–
HCl, pH 6.8, 7.5 mL per 100 mL glycerol, 20 mg mL1 SDS and
2.5 mL per 100 mL 2-mercaptoethanol. Aer heating at 100 C
for 5 min, each sample was loaded on the gel. SDS-PAGE was
carried out on 7  8 cm 12% polyacrylamide gels, using a mini-
Protean III cell (Bio-Rad). The gels were stained with Coomassie
blue.7 The gels were digitalised in an Epson Perfection V500
Scanner and analysed with ImageMaster 1-D Elite Soware (GE
Healthcare, Milan, Italy).
2.4 Western blotting
The proteins in gels were transferred to 0.45 m-pore nitrocellu-
lose membranes (Protran, 110 Whatman, Dassel, Germany) by
using the TE 77 PWR Semidry Transfer Unit (Amersham376 | Food Funct., 2014, 5, 375–380Biosciences), according to Towbin, Staehelin and Gordon.8
g-Conglutin was immune-detected as already described by
Magni.9
2.5 Pasta preparation and protein inclusion
Pasta supplied to the animals was amix of commercial dry pasta
and dry test pasta, including selected protein fractions from
lupin seeds and ovalbumin, as the control. Test pasta contain-
ing g-conglutin concentrate was mixed with commercial pasta
in a 1/4 ratio (w/w); a+b+d-conglutin isolate and ovalbumin
containing pasta were mixed with commercial pasta in a 1/8
ratio (w/w). All pasta samples were uncooked to allow easy
grinding to a ne powder.
Test pasta was prepared according to standard protocols.
Durum wheat semolina of good pasta-making performance
(protein: 14.3 g per 100 g d.w.; dried gluten: 13.2 g per 100 g) was
supplied by Molino Grassi (Parma, Italy). Semolina and protein
fractions (1 g per 100 g semolina and 1 g per 100 g each of the
lupin protein fraction and commercial ovalbumin) were mixed
with water (kept at 40 C) to produce a mixture with a nal
moisture content of 34%. Aer mixing for 10 minutes, each
blend was extruded and formed into a macaroni shape (7 mm
external diameter) using a continuous pilot-scale plant (20 kg
h1; MAC 30, Italpast, Parma, Italy). Fresh pasta was nally
dried in a pilot-scale drier (50 kg h1, Braibanti, Milan, Italy)
using a low-temperature drying cycle (50 C max. for 14 h),
according to Marti, Seetharaman and Pagani.10
2.6 Animal care and diets
Forty eight male Sprague Dawley rats weighing 195.7  13.5 g
were adapted to a standard diet, consisting of commercial pasta
(80.5%), casein (10%), Arbocel (4%), minerals (3.5%), olive oil
(1%) and vitamins (1%) for seven days. Tap water containing
10% glucose was supplied ad libitum to the animals during the
adaptation phase, in order to induce a hyperglycemic state and
also during the subsequent three week experimental period
with test pasta.
Between the adaptation phase and the test period, glucose
administration was suspended for 12 hours and the glucose
plasma levels were measured.
All procedures involving rats and their care were performed
according to the Italian Law on animal tests (D.L. 116/1992).
2.6.1 Chronic treatment with test pasta. The test diet
consisted of the above mentioned diet (adaptation diet) with the
substitution of part of the commercial pasta with a corre-
sponding amount of test pasta samples. The animals (24) were
divided into 3 homogenous groups, according to their blood
glucose concentration. The animals were fed ad libitum with a
diet containing pasta supplemented with lupin g-conglutin
concentrate, a+b+d-conglutin isolate and ovalbumin, respec-
tively, for three weeks. Glucose containing water was freely
available. Every day the food intake and the body weight of each
animal were measured. At the end of the experimental period,
the animals were fasted for 12 hours, sacriced, and the blood
was collected for the determination of glycaemia, insulin and
other hormone concentrations.This journal is © The Royal Society of Chemistry 2014
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View Article Online2.6.2 Acute treatment with test pasta (glucose overload
trial). At the end of the adaptation period, 24 untreated animals
were divided into 3 homogenous groups, according to their
blood glucose concentration. The animals were fasted for
20 hours. Then, 10 g of g-conglutin, a+b+d-conglutins and
ovalbumin supplemented pasta samples were supplied to the
animals, which they ate entirely within 30 minutes. Immedi-
ately aer this meal, 2 g kg1 of D-glucose was administered to
the animals by gavage. Before the meal and 30–60–90–120
minutes aer glucose administration, blood glucose was
determined.2.7 Blood analysis
Glucose concentrations were measured using a kit, based on an
enzymatic method of detection, purchased from R-Biopharm
(Germany). Insulin, leptin and total ghrelin were assayed using
ELISA commercial kits from Millipore Corporation (USA) and
the microplate reader 3550 (BioRad, Milan, Italy).Fig. 1 SDS-PAGE under reducing conditions of the protein fractions
added to pasta. Lane A: isoelectric precipitate; lane B: Zn2+ precipitate
(containing primarily g-conglutin); lane C: ovalbumin; lane M: marker
proteins. gC: g-conglutin reference, TPE: total protein extract
reference.2.8 Statistical analysis
The data obtained were analyzed by the SAS statistics program
(SAS Inst., Cary, NC, USA) version 9.2, using the procedure of
G.L.M. (General Linear Model) of the soware and adopting the
following experimental model:
y ¼ m + a + 3
where: y ¼ parameters (blood glucose, daily weight gain, food
intake, etc.); m ¼ population means; a ¼ eﬀect of protein type
(g-conglutin, a+b+d-conglutins, ovalbumin); 3 ¼ experimental
error.
Analysis of variance was carried out on the data collected by
using the above cited soware.
The Bonferroni test was used to compare the means. The
diﬀerences were considered signicant at P < 0.05. The rela-
tionships between variables were determined by means of
Pearson's correlation coeﬃcient, using the soware PROC
CORR of SAS 9.2.3. Results
3.1 Electrophoretic analysis of the protein fractions
included in the pasta samples
The two isolated lupin protein fractions and ovalbumin, which
were included in the test pasta dough at a dose of 1 g per 100 g,
were submitted to SDS-PAGE under reducing conditions and
the resulting proles are shown in Fig. 1. By comparing the
electrophoretic patterns with the g-conglutin and total protein
extract references and on the basis of previous separations and
mass spectrometry analysis,11 it was concluded that the lane B
of Fig. 1 contained primarily g-conglutin, while the lane A
consisted of the other main lupin cotyledonary proteins, that is
a+b+d-conglutins, which, having an acidic pI, precipitated at pH
4.5–5.0 (see details under Methods, paragraph 2.2). These latter
proteins consisted mainly of 11S- (legumin-like), 7S- (vicilin-
like) and 2S-globulins, respectively. For a molecularThis journal is © The Royal Society of Chemistry 2014characterization of these proteins see the reference Duranti,
Consonni, Magni, Sessa, and Scarafoni.12
Densitometric analysis of the lane B showed that the poly-
peptides corresponding to g-conglutin, that is the bands of 30
and 17 kDa, amounted to about 50% of the total proteins in the
lane. Therefore the actual amount of g-conglutin in the test
pasta samples was calculated to be 0.5 g per 100 g. According to
this nding and to the ratio 1 : 4 by weight of the mix between
test pasta and commercial pasta, the concentration of pure
g-conglutin in the pasta mix supplied to rats with the diet was
0.125 g per 100 g, corresponding to the same amounts of a+b+d-
conglutins and ovalbumin in the respective test pasta products.3.2 Chronic eﬀects of pasta intake on rat growth parameters
and basal blood glucose levels
The eﬀects of the three test pasta products on the rat body
parameters measured aer the adaptation period and the
induction of a hyperglycemic condition are reported in Table 1.
Considering the amounts of added proteins in the pasta fed to
the animals each day and the average daily intake and body
weight, it was calculated that the dosages of supplemented
proteins were about 90 mg per kg per day.
Initial weights of the rats did not diﬀer in the three groups,
while diﬀerences were marked at the end of the 3 weeks trial: in
particular a lower body weight was observed for rats fed the a, b
and d-conglutin isolate compared to animals fed the ovalbumin
supplemented pasta. The food intake of rats fed g-conglutin
concentrate supplemented pasta was also remarkably and
signicantly lower than that observed with rats fed ovalbumin
supplemented pasta.Food Funct., 2014, 5, 375–380 | 377
Table 1 Growth parameters and food intake of rats fed pasta supplemented with lupin g-conglutin concentrate, a+b+d-conglutin isolate and
ovalbumin for three weeks. For each of the three treatments, a separate set of eight rats was used. Data are presented as means  standard
deviationa
Treatment (n ¼ 8) Initial weight (g) Final weight (g) ADG* (g per day) Food intake (g per day) CI§
g-Conglutin concentrate 192.98  20.17 345.50  34.22ab 5.87  1.28 18.46  2.66a 3.22  0.49
a+b+d-Conglutin isolate 195.03  10.41 331.83  11.60a 5.26  0.36 18.76  0.89ab 3.57  0.14
Ovalbumin 199.02  8.97 370.20  10.76b 6.58  0.42 21.32  1.41b 3.24  0.21
a * ADG: average daily gain; § CI ¼ conversion index (food intake/growth); a,b P > 0.05 (Bonferroni test).
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View Article OnlineThe constancy of the conversion index (CI) for all samples
suggested a similar eﬃciency of the three groups in converting
food to energy.
Table 2 reports the fasting glycaemia levels observed at the
beginning and the end of the treatment. Glycaemiameasured in
rats fed lupin protein supplemented pasta for three weeks did
not signicantly diﬀer from that measured with ovalbumin.
At the end of the treatment, no statistically signicant
changes in hormone levels between the lupin protein supple-
mented pasta and the ovalbumin supplemented pasta fed
animals were monitored (Table 2), also due to the great
variability.3.3 Correlations between the measured parameters
All the measured parameters have been correlated by using the
Pearson correlation coeﬃcient in order to investigate the
possible inter-dependences, as described under Methods and
shown in Table 3.
Aer the chronic treatment, blood glucose, food intake,
growth and leptin blood level of treated animals correlated
positively: higher food intake induced higher growth and gly-
caemia; leptin is produced by adipose tissue, therefore higher
growth induced higher release of leptin. Leptin and insulin also
correlated positively, according to Amitani, Asakawa, Haruka,
and Inui.13 In our experiment both hormones were directly
related and this could be due to the positive relationship
between insulin and live weight. Since leptin is related to body
weight, we could hypothesize that heavier animals have higher
concentrations of insulin and leptin. Anyway the positive rela-
tionship between insulin and leptin observed in our experiment
is a quite common nding.14
The interpretation of the positive relationship between
ghrelin and leptin is more complex.15Usually the trends of these
two hormones are opposite, but they are strongly aﬀected byTable 2 The fasting glycaemia and energy metabolism-related horm
concentrate, a+b+d-conglutin isolate and ovalbumin for three weeks. F
Data are presented as means  standard deviationa
Treatment (n ¼ 8)
Initial glycaemia
(mg dL1)
Final glyca
(mg dL1)
g-Conglutin concentrate 132.33  9.95 131.83  1
a+b+d-Conglutin isolate 133.83  6.18 131.33  2
Ovalbumin 134.00  6.20 135.17  1
a Bonferroni test: the eﬀect of protein type did not result signicant for a
378 | Food Funct., 2014, 5, 375–380blood glucose. When glycaemia is high, ghrelin inhibits leptin,
while at lower glucose concentrations this does not happen.163.4 Glucose overload trial with test pasta samples
The animals (24) fed the adaptation diet for one week to induce
hyperglycemia and fasted for 20 hours were submitted to the
glucose overload trial. During the 20 hour fasting, rats were
allowed to drink tap water with no glucose added. Then, as
detailed under Methods, 10 g of g-conglutin concentrate,
a+b+d-conglutin isolate and ovalbumin supplemented pasta
samples were given to the animals, which entirely ate them
within 30 minutes. Immediately aer this meal, blood glucose
was determined and 2 g kg1 of D-glucose was administered to
the animals by gavage. The amount of administered g-conglutin
in this experiment corresponded to about 45 mg per kg body
weight. The glycaemia levels every 30 min for two hours of the
glucose overload trial are reported in Table 4. Major changes
were observed up to 60 min from the treatment, with statisti-
cally signicant lower increments for g-conglutin concentrate
supplemented pasta. At 90 minutes all plasma glucose levels
reached a maximum and then declined at 2 hours, steadily
approaching the basal levels.
A global estimation of the glycaemia trend is depicted by the
incremental areas under the curve (AUC) of the glucose overload
trial, reported in Fig. 2. As it can be seen, the plasma glucose
reduction by g-conglutin concentrate was apparent already at
the rst 30 min, though the diﬀerences were not statistically
signicant. Conversely, large and statistically signicant
diﬀerences were visible at 60 min and up to 90 minutes, where
the AUCs induced by the g-conglutin concentrate included in
pasta were dramatically lower than those obtained with pasta
supplemented with ovalbumin. This nding is consistent with
the glucose-lowering activity of lupin g-conglutin previously
measured with the puried protein administered by gavage inone levels in rats fed pasta supplemented with lupin g-conglutin
or each of the three treatments, a separate set of eight rats was used.
emia Insulin
(ng mL1)
Leptin
(ng mL1)
Ghrelin
(ng mL1)
2.92 0.75  0.68 1.59  1.10 0.20  0.19
2.66 0.59  0.33 2.03  0.46 0.15  0.05
7.77 0.86  0.08 2.14  1.06 0.21  0.09
ny analyzed parameters (P > 0.05).
This journal is © The Royal Society of Chemistry 2014
Table 3 Correlation (r, Pearson's coeﬃcient) between blood and growth parametersa
Glycaemia Insulin Ghrelin Leptin Weight Intake CI ADG
Glycaemia $ 0.393† NS 0.452* 0.521** 0.540** NS 0.463*
Insulin $ 0.424* 0.625* 0.462* NS 0.500* 0.405*
Ghrelin $ 0.437* NS NS NS NS
Leptin $ 0.706** 0.567** 0.582** 0.649**
Weight $ 0.937** 0.752** 0.955**
Intake $ 0.606** 0.907**
CI $ 0.861**
ADG $
a CI ¼ conversion index (feed/gain); ADG ¼ average daily gain; * P < 0.05; ** P < 0.01; † P ¼ 0.064.
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View Article Onlinerats.5 However, in the present work the protein was supple-
mented into a traditional food.Fig. 2 Incremental areas under the curve (AUC) of the glucose
overload trial. Plasma glucose variations upon administration of pasta
supplemented with lupin g-conglutin concentrate (black bars), a-, b-
and d-conglutin isolate (light grey bars) and ovalbumin (grey bars) to
eight animals for each group. Values are expressed as arbitrary units
(a.u.). a,bP > 0.05 (Bonferroni test).4. Discussion
In this work, the chronic and acute eﬀects of lupin protein
fractions physically entrapped into a common food matrix on
selected body parameters and plasma glucose levels of rats were
studied. Fasting blood glucose levels were in the same range as
reported by previous works focusing on glycemic response to
diets with diﬀerent glycemic index or supplemented with
g-conglutin.2,17 An unforeseen nding of this work was the
remarkable reduction in food intake and body weight increase
induced by pasta supplemented with the lupin protein fractions
with respect to the ovalbumin control. Regardless of the hypo-
glycaemic activity, that is a peculiar property of g-conglutin,2,3
all lupin proteins showed a relevant eﬀect on satiety and weight
gain, although the mechanism of action is far from being
understood. Although this result is somehow consistent with a
former report by Lee et al.,18 who monitored higher satiety and
lower energy intake in human subjects fed with lupin enriched
bread, the experimental plans of the two works strongly
diﬀered, beside being conducted on human subjects and rats.
In particular, while these authors included lupin kernel our in
bread, thus providing also lupin bers, of which the satiating
role had already been assessed,19 in our case only puried
proteins and at very low dosages were used as supplements.
Therefore, although a synergic eﬀect between proteins and
bers could reasonably be expected, in our work the observed
diﬀerences can be attributed to the protein fraction, only.Table 4 Glycaemia variations upon glucose overload in hyperglycemic
a+b+d-conglutin isolate and ovalbumin. For each of the three treatment
standard deviationa
Treatment (n ¼ 8) Initial glycaemia (mg dL1)
Glycaemi
30 minut
g-Conglutin concentrate 134.13  21.60 158.75 
a+b+d-Conglutin isolate 145.00  25.86 182.75 
Ovalbumin 137.63  17.91 173.25 
a a,b P > 0.05 (Bonferroni test).
This journal is © The Royal Society of Chemistry 2014The further notable nding of this work concerned the
lowering of the acute glycaemic curve, especially at early times
from the initial glucose load, and AUCs specically induced by
g-conglutin concentrate supplemented pasta. This result
conrms previous ndings obtained with pure2,5 and raw3
g-conglutin, thus substantiating its role as a plasma glucose-
controlling natural agent. However, in the present work the
biologically active protein has become a component of a foodrats fed 10 g pasta supplemented with lupin g-conglutin concentrate,
s, a separate set of eight rats was used. Data are expressed as means 
a (mg dL1) aer glucose overload
es 60 minutes 90 minutes 120 minutes
26.28 157.63  12.32a 187.63  32.83 154.50  22.46
34.89 178.25  20.36a,b 192.13  40.39 155.00  13.77
30.79 196.75  35.16b 192.13  47.30 158.50  16.90
Food Funct., 2014, 5, 375–380 | 379
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View Article Onlinematrix, while in the previous works it was administered by
gavage. Other teams have evidenced glycaemia-reducing eﬀects
of lupin ours in type II diabetic patients;20 however, the
authors admitted that their ndings could have been aﬀected
by the lower carbohydrate content in the lupin meal with
respect to the control. Still, pieces of evidence on the specic
role played by lupin ours and its components in controlling
plasma glucose concentrations are accumulating in the
literature.21,22
The long term eﬀect on glycaemia was less evident as
compared to a previous work,5 likely because g-conglutin intake
through the meal was less controlled in this than in that work,
where the protein was administered daily by gavage.
To the best of our knowledge, this work represents the rst
report on the eﬀects of a biologically active protein included
in a food matrix. Indeed food processes (mechanical forces,
high temperatures, pressures, etc.) could inuence protein
intrinsic properties and aﬀect the interactions with other
food components. However, it appears from our results that
the physical entrapment of g-conglutin in the pasta matrix
has not hampered its biological activity. It can be argued that
the resulting diminished accessibility of the lupin protein to
gastric enzymes and extreme low pH may have preserved the
g-conglutin covalent structure and allowed its transit into
duodenum in an intact and active form. As a matter of facts,
g-conglutin was shown to be fully resistant to digestive
enzymes with optimum pH at neutral values.23 In the present
study, the heating eﬀect on protein bio-activity could not be
evaluated since pasta was administered to the animals
without cooking. However, the presence of intact g-conglutin
in brine-cooked seeds has been detected (Capraro, unpub-
lished results), although the protein showed decreased
solubility, probably due to interactions with other lupin
proteins.
This work showed the feasibility of supplementing a tradi-
tional food with selected bioactive proteins, whose activities are
not inuenced by the inclusion. It can be stated that even low
amounts of lupin proteins had unforeseen eﬀects on body
weight gain, satiety and glycaemia. These ndings open new
perspectives for the exploitation of lupin g-conglutin for the
prevention and accompanying therapies of the many glucose-
related diseases and, more in general, of the lupin proteins in
weight controlling dietary programs.
5. AbbreviationsADG380 | Food Funct., 2014, 5,Average daily gain
AUC Area under the curve
CI Conversion index
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